), the world's largest pharmaceutical company,
on Monday it is purchasing a consumer healthcare business.
The marquee products for Ferrosan, which is based in Copenhagen,
include dietary supplements and lifestyle products. Pfizer, of New
York, is expected to strengthen its dietary supplement portfolio by
buying the line from Altor 2003 Fund GP.
"Ferrosan is an excellent strategic fit that strengthens our
presence in dietary supplements with a new set of compelling brands
and product pipeline," Paul Sturman, president of, Pfizer Consumer
Healthcare, said in a statement. "The transaction will mark an
important step towards expanding Ferrosan's brands through Pfizer's
Based in the Nordic region, Ferrosan has been building a strong
brand for consumer healthcare since 1920. Its serves Russia,
Eastern Europe and Turkey, among other nations.
"We are very pleased that Ferrosan's innovative portfolio of
leading brands will be joining Pfizer," Ferrosan president Ola
Erici said in a statement. "We expect that, as part of the Pfizer
portfolio, our products will build on their industry-leading
positions and become available in more countries around the world.
And, at the same time, Pfizer will be able to leverage its
footprint in key Ferrosan markets with new Pfizer products."